Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$4.44 - $0.82. Add difference to $4.44 when it breaks out.
It's just a guide on what the price can become at the present trajectory. May just jump to the $20s or $30s for all I know. Or $0.50 if P3 fails and suddenly LEAPS is everybody's straw.
Fannie will pop if he grabs it really hard this time.
if above $3 today then it's blast off. There can only be that many fake breaks.
$8.06 the next price level. I hope it skids over to $11.
That's pittance.
My conspiratorial mind thinks that either
1) everyone is holding back knowing they can always buy at low low price just before the big announcement once a share price crisis occurs, like say...cough cough...a hit piece is generated.
or
2) Satisfied and thanking God there's at least a salary for the past 30 years from investors who believe their widget. Thank God.
That sounds better. But with Furrystein in the picture, the price should now go over a cliff at the opening.
If that happens and Geert AND company buys a lot, then it's game on. Otherwise it's cooked.
I am always curious why Geert is the only insider with so many shares. Wouldn't the Chief Scientific Officer want to be rich also with such a wonderful product, for example.
2. The FDA withdrew the hold because they knew of potential benefit
Huh? How do you know that was the reason the FDA withdrew the hold?
Membership selling bait blog.
Go to Yahoo GERN and read all the chatter from July 2018 until the crash. See if it's like looking into a mirror.
It either means he is getting ready to sell higher, or he is getting ready to bail some out before a hit happens. There's no way to tell which is it.
But a VP from GERN sold a chunk at $7 and got jeered by investors who thought he was nuts. He wasn't. He knew exactly what was going to happen. So I am very mindful to want to know if Geert sold 148,000 shares.
CVM starting to look like GERN. People on message boards talking about how much the price it should be and what higher price to sell and how CVM will get bought out before results.
GERN boards were full of excitement about how JNJ was going to BO them because of this and that, then crashed to $1 from $7.
The chatter in CVM gets me nervous.
Did Geert really sell his shares? Any confirmation?
Poser posts are really detestable and worrying at the same time.
Yeah, join the class action suit.
Why wasn't it asked at the CC the reason for the Imet Pricing Managers and Janssen's patent filing?
It's going pass $8 quite soon.
EU approval could be as soon as next month.
This is the basis for the "tantamount to a cure" remark. It really cannot be more plain.
Somebody's buying....
A cannabis company is worth $21B and Geron is worth $1B????? Shouldn't this be other way around? Crazy.
Stops triggering hit piece for shorts to get out. Those who couldn't will be the ones behind the super squeeze soon.
From "3 Stocks to Watch as Immunotherapy Pushes Biotech Growth"
Ibrutinib also goes by the trade name, Imbruvica, which is owned by Abbvie's Pharmacyclics and had received additional development from Johnson & Johnson's (JNJ) Janssen subsidiary. Imbruvica recorded net revenues for 2017 of $2.573 Billion.
~
JNJ dropped that one Baaaaad......
Scanning through all the hundred of billion in market caps of every large pharma there is and looking again at what GERN with a market cap of only $1B yet doing what none of these big pharmas can do in cancer treatment efficacy.....I think....yeah......it's TO DA MOON......no doubt about it.
Rarely you see Yahoo 1st year target for a stock get exceeded.
Just buy and hold and pass the shares on to the next generation. The science is sound but still hasn't heard of anyone cured of cancer yet. While continuation by JNJ is pretty much set, it is unlikely they want to buyout GERN now without regulatory approval of Imetalstet. I don't see their rush when they already hold the good cards. A rival buying 20% of GERN isn't that big a deal. Cancer is too huge a field for anyone to dominate so until such a time the likely trajectory of GERN is a decades long climb to $200 like APPL.
Even the much compared PCYC buyout did not get to the buyout price from $5 overnight. That took 6 years! So why would GERN leap from $6 today to a buyout of over $100 in a month? Was there ever a stock like that? Remember there is still no cure, just great potential.
The big surprise will be when JNJ offers continuation but GERN says no they will go it alone or partners someone else because they are getting a puny deal from JNJ. Not sure if their agreement allows GERN a say.....But that will be very very interesting.....also utterly traumatic to the share price in the short term but is an opportunity to buy more for the long ascend.
Huge day tomorrow. The roof's getting blown off.
Shouldn't continuation announcement be just a formality buy now. Sorry, couldn't resist.....
Compassionate Use sounds great, doesn't it? Kinda lets the drug maker do field test without the risk of blow back. Also means time needed to see if the drug works before any further decision.
Pity, it looked like a rocket pack was strapped on last week. Bought in too early.
No indication of buyout. Just continuation. This is going to suck.
Erm....so someone in JNJ told you there is a buyout? Do share.
This is a good chuckle, but there isn't going to be a buyout. It is way too early for this consideration. Probably reach $8 before the shorts take control again.
Another 40M volumn day in the making. Perhaps 50M. Shorts are running.
This will shoot, non-event regardless. Why have a Pricing Manager unless you are selling something....or have PLANS. The market can't unsee this.
Non-event is just PR speak to douse sentiment. But the competitors are on notice about Imetelstat on the move, for sure! 20% Geron outstanding is 20% profit-sharing with anybody who buys these shares.
Hmmm....Geert posting the same message again?
I may be wrong about a short squeeze though that is what is happening now. Behind the apparent short squeeze may be a buyout. Why else will there be a double posting?
And this is still just the beginning.....$5 in a couple of days.
All sentiment moves. The short squeeze game is ON.....big time.
Yankee, I once took you for a fraud pumper. My apologies. You have been correct all these years.
Could hit $5 and beyond from this move - IN A WEEK.
What you said rings true. Doctors will have to adopt once FDA approves to avoid lawsuits. The new SOC need not be mandated by the FDA at all.. It will just become de facto.
Down 6% for now...if it turns positive within a few hours I will HATE to be a short.
It feels different this time. We will know at the end of the day.
Hmmm.....that is an enlightening reply. Yankee. Thank you.